Drei bedeutende deutsche Universitäten haben eine Kooperation für ein innovatives Forschungsprojekt bekannt gegeben. Ziel ist es, eine neue Testplattform für molekulare Kommunikation zu entwickeln. Mehr dazu erfahren Sie in unserem Artikel.
Bewilligung eines neuen Drittmittelprojekts im Verbund mit der Universität Regensburg, der TH Deggendorf und der Friedrich-Alexander-Universität Erlangen-Nürnberg
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.